Generous $33,000 to diabetes research

A CHEQUE for $33,000 was presented to Associate Professor Wayne Hawthorne and Westmead Medical Research foundation’s Partnerships Manager, Susie Saba on behalf of Loxley on Bellbird Hill.

The money was raised at the inaugural, Dine In Style fundraising Degustation Dinner, a fundraising event for diabetes research and care which was held at Loxley on Bellbird Hill.

All the 140 tickets for the event sold out.

The generosity and goodwill of the event’s Gold Sponsors, Nova Employment, Pepe’s Ducks and Del Rio Riverside Resort along with local businesses and individuals were recognised and sincerely appreciated by Loxley on Bellbird Hill’s manager, Paul Maher.

Paul Maher and Loxley on Bellbird Hill have been long term supporters of My Westmead, the fundraising and charity arm of Westmead Hospital.

My Westmead works to provide ‘bench to bedside’ treatment and care, ensuring that breakthroughs and discoveries made by researchers are translated into actual outcomes for the patients. Susie Saba, the Partnership Manager at the Westmead Medical Research foundation, said she was over the moon when the team at Loxley on Bellbird Hill came up with the fundraising idea.

“We were delighted when Paul and his team had the idea of supporting My Westmead with an event at their beautiful venue,” Ms Saba said.

“For the generosity of everyone who helped raise $33,000, I just want to say thank you,” she added.

During the cheque presentation Associate Professor Wayne Hawthorne gave a tour of the Westmead Institute for Medical Research, whilst detailing how the funds raised will help My Westmead support diabetes research and care.

“We have come so far in treatment options for Type 1 Diabetes, but we won’t stop until we find a cure,” Professor Hawthorne said.

Associate Professor Hawthorne, who was also guest speaker at the event, leads a specialised team of professionals committed to providing patients with the best possible treatments for Type 1 diabetes.

They are working to find a cure for Type 1 Diabetes and to help patients that suffer from secondary complications such as renal failure.